|
 |
European BioPharmaceutical Review
|
| The industry developments of the last decade have changed the shape of the pharmaceutical and biotech industry. With the consolidation of the pharma industry in the last decade and the increasing size of companies, R&D productivity, at least in relative terms, seems to be insufficient to support the growth expected by shareholders. The underlying need for alliances on the part of 'big pharma' in order to fuel growth by ensuring access to new products, and optimising drug development and commercialisation, seems to go from strength to strength. This has driven over 7,000 alliances worldwide between pharma and biotech companies from 1996 to 2002. At the same time, the total value of alliances has seen an explosion in growth from US$7 billion in 1996 to US$18 billion in 2002 - an increase of more than 150 per cent as big companies compete for the same assets. Alliances have surged to the point that most pharmaceutical companies see each other as potential partners; a remarkably different view compared to doing business 10 to 15 years ago. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EuroBiopartnering 2008
7-9 October 2008, Paris, France
EuroBiOpartnering
2008 gives you the unique opportunity to meet the relevant decision makers and
opinion leaders from the international biotech community and offers you 3 days
of partnering opportunities including one-to-one meetings, company presentations
and further networking activities…
More info >> |
|
 |
News and Press Releases |
 |
“PACK DIFFERENT” with EMBALLAGE 2008
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
